🔗 Visit the ClinicalTrials.gov page for NCT00537628
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. | J Am Coll Cardiol | 2010 | 2.25 |
| 2 | Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. | Circ Heart Fail | 2011 | 1.05 |
| 3 | Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. | J Am Coll Cardiol | 2011 | 1.01 |
| 4 | Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial. | Eur J Heart Fail | 2012 | 0.93 |
| 5 | Short-term mortality risk in emergency department acute heart failure. | Acad Emerg Med | 2011 | 0.84 |